In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation

Thymic stromal lymphopoietin (TSLP) potently induces deregulation of Th2 responses, a hallmark feature of allergic inflammatory diseases such as asthma, atopic dermatitis, and allergic rhinitis. However, direct downstream in vivo mediators in the TSLP-induced atopic immune cascade have not been iden...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Seshasayee, Dhaya, Lee, Wyne P., Zhou, Meijuan, Shu, Jean, Suto, Eric, Zhang, Juan, Diehl, Laurie, Austin, Cary D., Meng, Y. Gloria, Tan, Martha, Bullens, Sherron L., Seeber, Stefan, Fuentes, Maria E., Labrijn, Aran F., Graus, Yvo M.F., Miller, Lisa A., Schelegle, Edward S., Hyde, Dallas M., Wu, Lawren C., Hymowitz, Sarah G., Martin, Flavius
Format: Artigo
Langue:Inglês
Publié: American Society for Clinical Investigation 2007
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2096422/
https://ncbi.nlm.nih.gov/pubmed/18060034
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI33559
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires